Josh Yuan - Concepedia

Author

Josh Yuan

Also Known As

J. Yuan, Josh J. Yuan, Josh Yuan

Publications

290

Citations

H-Index

Concepts

All Affiliations

Josh Yuan is an author at Takeda (United States) specializing in clinical immunology, inflammatory arthritis, and tumor immunity.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	14
2	Cell Biology	1	1	14
3	Clinical Immunology	1	1	14
4	Immunology	1	1	14
5	Rheumatology	1	1	14

Josh Yuan

Publications

171

Citations

H-Index

Page 1

	Year	Citations
Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human Josh Yuan, Dai-chang Yang, Ji Y. Zhang, Drug Metabolism and Disposition	2002	53
Pharmacokinetics and Metabolism of a COX-2 Inhibitor, Valdecoxib, in Mice Ji Y. Zhang, Josh Yuan, Yue-Fen Wang, Drug Metabolism and Disposition	2003	40
Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey S. K. Paulson, J. Y. Zhang, Susan M. Jessen, Xenobiotica	2000	27
A Reduction in B, T, and Natural Killer Cells Expressing CD38 by TAK-079 Inhibits the Induction and Progression of Collagen-Induced Arthritis in Cynomolgus Monkeys Wouter Korver, Mary Carsillo, Josh Yuan, Journal of Pharmacology and Experimental Therapeutics	2019	25
TAK-079 is a high affinity monoclonal antibody that effectively mediates CD38+ cell depletion Glennda Smithson, Jonathan Zalevsky, Wouter Korver, The Journal of Immunology Clinical ImmunologyCd38+ Cell DepletionImmunologyImmune RegulationImmunologic Mechanism	2017	14
Pharmacokinetics and pharmacodynamics of the cytolytic anti‐<scp>CD</scp>38 human monoclonal antibody <scp>TAK</scp>‐079 in monkey – model assisted preparation for the first in human trial Stefan Roepcke, Nele Plock, Josh Yuan, Pharmacology Research & Perspectives	2018	12

Page 1